Multi-kinase inhibitor T-1301
Term · Oncology and biomedicine · MLC-T-ONC-015355
An orally bioavailable small molecule inhibitor of multiple as of yet undisclosed kinases, with potential antineoplastic activity. Upon oral administration, multi-kinase inhibitor T-1301 inhibits the activity of multiple as of yet undisclosed kinases. This may result in antitumor activity in tumor cells in which these kinases are upregulated or dysregulated.
| Identifier | MLC-T-ONC-015355 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | multiple kinase inhibitor T-1301 |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-015355",
"term": "Multi-kinase inhibitor T-1301",
"field": "Oncology and biomedicine",
"definition": "An orally bioavailable small molecule inhibitor of multiple as of yet undisclosed kinases, with potential antineoplastic activity. Upon oral administration, multi-kinase inhibitor T-1301 inhibits the activity of multiple as of yet undisclosed kinases. This may result in antitumor activity in tumor cells in which these kinases are upregulated or dysregulated.",
"synonyms": [
"multiple kinase inhibitor T-1301"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/multi-kinase-inhibitor-t-1301/"
}
Record 11,414 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.